JP

Hiroshi Teraoka

This inventor holds 0 USPTO granted patents, plus 2 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Teraoka. Retrieved from https://idiyas.com/inventor/hiroshi-teraoka-oa3llen3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Hiroshi Teraoka: Innovator in Protein Production

Introduction

Hiroshi Teraoka is a notable inventor based in Japan. He has made significant contributions to the field of protein production, particularly in the development of novel methods and proteins. Despite having 0 patents, his work has garnered attention in the scientific community.

Latest Patents

Teraoka's latest patents include a new reg protein, which features an amino acid sequence that begins with a glutamine residue at the 20th position from the amino terminus and terminates with an asparagine residue at the 165th position. This innovative reg protein may also contain an additional methionine residue at the amino terminus. Another significant patent is a novel method for producing glucagon. This method involves preparing a fusion protein characterized by a specific formula and treating it with an enzyme that hydrolyzes peptide bonds at the carboxyl termini of glutamic acid residues, leading to the cleavage of the fusion protein.

Career Highlights

Throughout his career, Hiroshi Teraoka has worked with various companies, including Jun Ishizaki and Mikio Tamaki. His experience in these organizations has contributed to his expertise in protein research and development.

Collaborations

Teraoka has collaborated with notable individuals in his field, including Jun Ishizaki and Mikio Tamaki. These partnerships have likely enhanced his research and innovation capabilities.

Conclusion

Hiroshi Teraoka is a dedicated inventor whose work in protein production has the potential to impact various scientific applications. His innovative approaches to developing proteins and methods demonstrate his commitment to advancing the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…